No Data
Research Alert: CFRA Lowers Rating On Shares Of Lazard, Inc. To Hold From Buy
Express News | JMP Securities Reiterates Market Outperform on Lazard, Maintains $55 Price Target
Lazard Analyst Ratings
Lazard Ltd's Mixed Earnings Call: Growth Amid Challenges
Dealmaking Remains Uncertain, Lazard Banker Says: 'We're Not in Normal Times.'
Earnings Call Summary | Lazard(LAZ.US) Q1 2025 Earnings Conference
104088143 : nice to
J Servai (JLAPT) : $MIRA Pharmaceuticals (MIRA.US)$
105232125 :
Tonyco : meanwhile, in reality:
104556909 : good